tiprankstipranks
Advertisement
Advertisement

RGEN Stock Latest News

Stifel sees Moderna data as positive for Repligen, Maravai
The FlyStifel sees Moderna data as positive for Repligen, Maravai
8d ago
MRNA
MRVI
Wells sees Repligen among key beneficiaries of Moderna’s cancer vaccine data
PremiumThe Fly
Wells sees Repligen among key beneficiaries of Moderna’s cancer vaccine data
8d ago
DHR
MRK
Repligen–BioLife Deal: Market, Integration and Regulatory Risks Threaten Growth Outlook and Shareholder Returns
PremiumCompany Announcements
Repligen–BioLife Deal: Market, Integration and Regulatory Risks Threaten Growth Outlook and Shareholder Returns
27d ago
RGEN
Repligen’s Operational Momentum Offset by Full Valuation; Kyle Mikson CFA Reiterates Hold with Unchanged $145 Price Target
PremiumRatings
Repligen’s Operational Momentum Offset by Full Valuation; Kyle Mikson CFA Reiterates Hold with Unchanged $145 Price Target
29d ago
RGEN
Repligen Stock (RGEN) Rises After Investors Wowed By ‘Market Leading’ Q2 Figures
PremiumMarket News
Repligen Stock (RGEN) Rises After Investors Wowed By ‘Market Leading’ Q2 Figures
29d ago
RGEN
Repligen price target raised to $175 from $165 at JPMorgan
PremiumThe FlyRepligen price target raised to $175 from $165 at JPMorgan
29d ago
RGEN
Repligen rises 15.4%
Premium
The Fly
Repligen rises 15.4%
30d ago
RGEN
Repligen Earns Buy Rating on Strong Q2 Beat, Raised Guidance, and Broad-Based Demand Strength
Premium
Ratings
Repligen Earns Buy Rating on Strong Q2 Beat, Raised Guidance, and Broad-Based Demand Strength
30d ago
RGEN
Repligen rises 16.2%
PremiumThe Fly
Repligen rises 16.2%
30d ago
RGEN
Repligen reports Q2 adjusted EPS 54c, consensus 45c
PremiumThe Fly
Repligen reports Q2 adjusted EPS 54c, consensus 45c
30d ago
RGEN
Repligen raises FY26 EPS view to $2.03-$2.09 from $1.97-$2.05, consensus $2.00
PremiumThe Fly
Repligen raises FY26 EPS view to $2.03-$2.09 from $1.97-$2.05, consensus $2.00
30d ago
RGEN
RGEN Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
RGEN Upcoming Earnings Report: What to Expect?
1M ago
RGEN
Midday Fly By: AT&T reports Q2 beat, AMD invests $5B in Anthropic
PremiumThe FlyMidday Fly By: AT&T reports Q2 beat, AMD invests $5B in Anthropic
1M ago
T
PM
BioLife Solutions downgraded to Hold from Buy at Lake Street
Premium
The Fly
BioLife Solutions downgraded to Hold from Buy at Lake Street
1M ago
BLFS
RGEN
Repligen to Acquire BioLife, Expanding Cell Therapy Reach
Premium
Company Announcements
Repligen to Acquire BioLife, Expanding Cell Therapy Reach
1M ago
8K
RGEN
Repligen Earns Buy Rating on BioLife Acquisition Synergies and Strong Organic Growth
PremiumRatings
Repligen Earns Buy Rating on BioLife Acquisition Synergies and Strong Organic Growth
1M ago
RGEN
Repligen to acquire BioLife Solutions for $31 per share, or $1.5B
PremiumThe Fly
Repligen to acquire BioLife Solutions for $31 per share, or $1.5B
1M ago
BLFS
RGEN
Repligen to acquire BioLife Solutions for $31 per share, or $1.5B
PremiumThe Fly
Repligen to acquire BioLife Solutions for $31 per share, or $1.5B
1M ago
BLFS
RGEN
SpaceX initiated, Cloudflare upgraded: Wall Street’s top analyst calls
PremiumThe Fly
SpaceX initiated, Cloudflare upgraded: Wall Street’s top analyst calls
2M ago
KC
AAL
Repligen upgraded to Buy from Hold at Benchmark
PremiumThe FlyRepligen upgraded to Buy from Hold at Benchmark
2M ago
RGEN
Repligen price target raised to $160 from $150 at Evercore ISI
Premium
The Fly
Repligen price target raised to $160 from $150 at Evercore ISI
2M ago
RGEN
Biolife attracts takeover interest from Repligen, Bloomberg says
Premium
The Fly
Biolife attracts takeover interest from Repligen, Bloomberg says
2M ago
BLFS
RGEN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >